These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 2118207)
1. The relationship between thermodynamics and the toxicity of gadolinium complexes. Cacheris WP; Quay SC; Rocklage SM Magn Reson Imaging; 1990; 8(4):467-81. PubMed ID: 2118207 [TBL] [Abstract][Full Text] [Related]
2. The synthesis and screening of nonionic gadolinium (III) DTPA-bisamide complexes as magnetic resonance imaging contrast agents. Periasamy M; White D; deLearie L; Moore D; Wallace R; Lin W; Dunn J; Hirth W; Cacheris W; Pilcher G Invest Radiol; 1991 Nov; 26 Suppl 1():S217-20; discussion S232-5. PubMed ID: 1667003 [No Abstract] [Full Text] [Related]
3. Extravascular toxicity of two magnetic resonance contrast agents. Preliminary experience in the rat. Cohan RH; Leder RA; Herzberg AJ; Hedlund LW; Wheeler CT; Beam CA; Nadel SN; Dunnick NR Invest Radiol; 1991 Mar; 26(3):224-6. PubMed ID: 2055727 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of nonionic paramagnetic metal complexes as potential magnetic resonance imaging contrast agents. White DH; Rajagopalan R; Kuan KT; Lin Y; Wallace RA; Rogic MM; Bosworth ME; Robbins MS; Ralston WH; Adams MD Invest Radiol; 1990 Sep; 25 Suppl 1():S56-7. PubMed ID: 2126534 [No Abstract] [Full Text] [Related]
5. New magnetic resonance imaging contrast agents for infarct imaging based on phosphonate derivatives of Gd-DTPA. Adzamli IK; Blau M; Pfeffer MA; Davis MA Invest Radiol; 1991 Nov; 26 Suppl 1():S242-4; discussion S245-7. PubMed ID: 1808139 [No Abstract] [Full Text] [Related]
6. Detailed toxicity studies of liposomal gadolinium-DTPA. Fritz T; Unger E; Wilson-Sanders S; Ahkong QF; Tilcock C Invest Radiol; 1991 Nov; 26(11):960-8. PubMed ID: 1835967 [TBL] [Abstract][Full Text] [Related]
7. Comparative transmetallation kinetics and thermodynamic stability of gadolinium-DTPA bis-glucosamide and other magnetic resonance imaging contrast media. Puttagunta NR; Gibby WA; Puttagunta VL Invest Radiol; 1996 Oct; 31(10):619-24. PubMed ID: 8889650 [TBL] [Abstract][Full Text] [Related]
8. The synthesis and evaluation of macrocyclic gadolinium-DTPA-bis(amide) complexes as magnetic resonance imaging contrast agents. Varadarajan JA; Crofts SP; Carvalho JF; Fellmann JD; Kim SH; Chang CA; Watson AD Invest Radiol; 1994 Jun; 29 Suppl 2():S18-20. PubMed ID: 7928223 [TBL] [Abstract][Full Text] [Related]
9. Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent. Harpur ES; Worah D; Hals PA; Holtz E; Furuhama K; Nomura H Invest Radiol; 1993 Mar; 28 Suppl 1():S28-43. PubMed ID: 8486501 [TBL] [Abstract][Full Text] [Related]
10. Tolerance of extracellular contrast agents for magnetic resonance imaging. Weinmann HJ; Press WR; Gries H Invest Radiol; 1990 Sep; 25 Suppl 1():S49-50. PubMed ID: 2283256 [No Abstract] [Full Text] [Related]
11. The functional effects of gadolinium-DTPA on the isolated perfused rat kidney. Brown PW; Haylor JL; Morcos SK; el Nahas AM Eur J Radiol; 1993 Feb; 16(2):85-9. PubMed ID: 8462585 [TBL] [Abstract][Full Text] [Related]
12. [A comparative study between Gd-BOPTA, a biliary excretion contrast medium, and Gd-DTPA in the magnetic resonance imaging of the rat liver]. Patrizio G; Pavone P; Cardone G; Pietroletti R; Passariello R; Tettamanti E; Musu C; Felder E Radiol Med; 1990 May; 79(5):458-62. PubMed ID: 2359853 [TBL] [Abstract][Full Text] [Related]
13. The use of a binary chelate formulation: Could gadolinium based linear contrast agents be rescued by the addition of zinc selective chelates? Gibby W; Parish W; Merrill RM; Fernandez D; Anderson CR; Merchel E; Parr R Magn Reson Imaging; 2019 May; 58():76-81. PubMed ID: 30639754 [TBL] [Abstract][Full Text] [Related]
14. Gadolinium(III) complex equilibria: the implications for Gd(III) MRI contrast agents. Jackson GE; Wynchank S; Woudenberg M Magn Reson Med; 1990 Oct; 16(1):57-66. PubMed ID: 2123958 [TBL] [Abstract][Full Text] [Related]
15. Effects of Gd-DTPA after osmotic BBB disruption in a rodent model: toxicity and MR findings. Roman-Goldstein SM; Barnett PA; McCormick CI; Szumowski J; Shannon EM; Ramsey FL; Mass M; Neuwelt EA J Comput Assist Tomogr; 1994; 18(5):731-6. PubMed ID: 8089321 [TBL] [Abstract][Full Text] [Related]
16. Gadolinium cryptelates as MR contrast agents. Knop RH; Frank JA; Dwyer AJ; Girton ME; Naegele M; Schrader M; Cobb J; Gansow O; Maegerstadt M; Brechbiel M J Comput Assist Tomogr; 1987; 11(1):35-42. PubMed ID: 3805426 [TBL] [Abstract][Full Text] [Related]
17. Gd-DOTA: characterization of a new paramagnetic complex. Bousquet JC; Saini S; Stark DD; Hahn PF; Nigam M; Wittenberg J; Ferrucci JT Radiology; 1988 Mar; 166(3):693-8. PubMed ID: 3340763 [TBL] [Abstract][Full Text] [Related]
18. Gadolinium-ethoxybenzyl-DTPA, a new liver-directed magnetic resonance contrast agent. Absence of acute hepatotoxic, cardiovascular, or immunogenic effects. Mühler A; Clément O; Saeed M; Lake JR; Stites DP; Berthezène Y; Brasch RC Invest Radiol; 1993 Jan; 28(1):26-32. PubMed ID: 8425849 [TBL] [Abstract][Full Text] [Related]
19. Experimental approach to the intra-arterial magnetic resonance imaging contrast media (Gd-DTPA-iodized oil) and new lipophilic gadolinium complex combined with iodized oil. Yoshikawa K; Shiono T; Yamashita T; Iwai H; Abe O; Hisamatsu K; Takenaka E Invest Radiol; 1994 Jun; 29 Suppl 2():S245-6. PubMed ID: 7928246 [No Abstract] [Full Text] [Related]
20. Advances in macrocyclic gadolinium complexes as magnetic resonance imaging contrast agents. Meyer D; Schaefer M; Doucet D Invest Radiol; 1990 Sep; 25 Suppl 1():S53-5. PubMed ID: 2132570 [No Abstract] [Full Text] [Related] [Next] [New Search]